Contraceptive Devices Market Size, Share and Industry Analysis By Product Type (Male & Female Contraceptive Devices, Technology (Hormonal & Barrier Contraceptives), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel & NGO & Others) and Regional Forecast, 2018 - 2032

Table of Content:

1.Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2.Executive Summary

3.Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4.Key Insights

4.1 Fertility Statistics - Key Countries, 2017

4.2 New Product Launch

4.3 Key Industry Trends

4.4 Regulatory Scenario - Key Countries

4.5 Key Technological Advancements

4.6 Recent Industry Developments - Partnerships, Mergers & Acquisitions

5.Global Contraceptive Devices Market Analysis, Insights and Forecast, 2014-2025

5.1. Key Findings/ Summary

5.2. Market Analysis, Insights and Forecast – By Product Type

5.2.1 Male Contraceptive Devices

5.2.2 Female Contraceptive Devices

5.2.2.1 Female Condoms, Diaphragms & Sponges

5.2.2.2 Vaginal Rings

5.2.2.3 Intrauterine Devices

5.2.2.4 Sub-dermal Implants

5.2.2.5 Others

5.3. Market Analysis, Insights and Forecast – By Technology

5.3.1 Hormonal Contraceptives

5.3.2 Barrier Contraceptives

5.4. Market Analysis, Insights and Forecast – By Distribution Channel

5.4.1 Hospital Pharmacy

5.4.2 Retail Pharmacy

5.4.3 Clinics

5.4.4 Online Channel

5.4.5 Public Channel & NGOs

5.4.6 Others

5.5. Market Analysis, Insights and Forecast – By Region

5.5.1 North America

5.5.2 Europe

5.5.3 Asia Pacific

5.5.4 Latin America

5.5.5 Middle East & Africa

6.North America Contraceptive Devices Market Analysis, Insights and Forecast,2014-2025

6.1. Key Findings/ Summary

6.2. Market Analysis, Insights and Forecast– By Product Type

6.2.1 Male Contraceptive Devices

6.2.2 Female Contraceptive Devices

6.2.2.1 Female Condoms, Diaphragms & Sponges

6.2.2.2 Vaginal Rings

6.2.2.3 Intrauterine Devices

6.2.2.4 Sub-dermal Implants

6.2.2.5 Others

6.3. Market Analysis, Insights and Forecast – By Technology

6.3.1 Hormonal Contraceptives

6.3.2 Barrier Contraceptives

6.4. Market Analysis, Insights and Forecast – By Distribution Channel

6.4.1 Hospital Pharmacy

6.4.2 Retail Pharmacy

6.4.3 Clinics

6.4.4 Online Channel

6.4.5 Public Channel & NGOs

6.4.6 Others

6.5. Market Analysis, Insights and Forecast – By Country

6.5.1 U.S.

6.5.2 Canada

7.Europe Contraceptive Devices Market Analysis, Insights and Forecast 2014-2025

7.1. Key Findings/ Summary

7.2. Market Analysis, Insights and Forecast – By Product Type

7.2.1 Male Contraceptive Devices

7.2.2 Female Contraceptive Devices

7.2.2.1 Female Condoms, Diaphragms & Sponges

7.2.2.2 Vaginal Rings

7.2.2.3 Intrauterine Devices

7.2.2.4 Sub-dermal Implants

7.2.2.5 Others

7.3. Market Analysis, Insights and Forecast – By Technology

7.3.1 Hormonal Contraceptives

7.3.2 Barrier Contraceptives

7.4. Market Analysis, Insights and Forecast – By Distribution Channel

7.4.1 Hospital Pharmacy

7.4.2 Retail Pharmacy

7.4.3 Clinics

7.4.4 Online Channel

7.4.5 Public Channel & NGOs

7.4.6 Others

7.5. Market Analysis, Insights and Forecast – By Countries/Sub regions

7.5.1 U.K.

7.5.2 Germany

7.5.3 France

7.5.4 Italy

7.5.5 Spain

7.5.6 Scandinavia

7.5.7 Rest of Europe

8.Asia Pacific Contraceptive Devices Market Analysis, Insights and Forecast,2014-2025

8.1. Key Findings/ Summary

8.2. Market Analysis, Insights and Forecast – By Product Type

8.2.1 Male Contraceptive Devices

8.2.2 Female Contraceptive Devices

8.2.2.1 Female Condoms, Diaphragms & Sponges

8.2.2.2 Vaginal Rings

8.2.2.3 Intrauterine Devices

8.2.2.4 Sub-dermal Implants

8.2.2.5 Others

8.3. Market Analysis, Insights and Forecast – By Technology

8.3.1 Hormonal Contraceptives

8.3.2 Barrier Contraceptives

8.4. Market Analysis, Insights and Forecast – By Distribution Channel

8.4.1 Hospital Pharmacy

8.4.2 Retail Pharmacy

8.4.3 Clinics

8.4.4 Online Channel

8.4.5 Public Channel & NGOs

8.4.6 Others

8.5. Market Analysis, Insights and Forecast – By Countries/Sub regions

8.5.1 Japan

8.5.2 China

8.5.3 India

8.5.4 Southeast Asia

8.5.5 Australia

8.5.6 Rest of Asia Pacific

9.Latin America Contraceptive Devices Market Analysis, Insights and Forecast,2014-2025

9.1. Key Findings/ Summary

9.2. Market Analysis, Insights and Forecast – By Product Type

9.2.1 Male Contraceptive Devices

9.2.2 Female Contraceptive Devices

9.2.2.1 Female Condoms, Diaphragms & Sponges

9.2.2.2 Vaginal Rings

9.2.2.3 Intrauterine Devices

9.2.2.4 Sub-dermal Implants

9.2.2.5 Others

9.3. Market Analysis, Insights and Forecast – By Technology

9.3.1 Hormonal Contraceptives

9.3.2 Barrier Contraceptives

9.4. Market Analysis, Insights and Forecast – By Distribution Channel

9.4.1 Hospital Pharmacy

9.4.2 Retail Pharmacy

9.4.3 Clinics

9.4.4 Online Channel

9.4.5 Public Channel & NGOs

9.4.6 Others

9.5. Market Analysis, Insights and Forecast – By Countries/Sub regions

9.5.1 Brazil

9.5.2 Mexico

9.5.3 Rest of Latin America

10 Middle East & Africa Contraceptive Devices Market Analysis, Insights and Forecast, 2014-2025

10.1. Key Findings/ Summary

10.2. Market Analysis, Insights and Forecast – By Product Type

10.2.1 Male Contraceptive Devices

10.2.2 Female Contraceptive Devices

10.2.2.1 Female Condoms, Diaphragms & Sponges

10.2.2.2 Vaginal Rings

10.2.2.3 Intrauterine Devices

10.2.2.4 Sub-dermal Implants

10.2.2.5 Others

10.3. Market Analysis, Insights and Forecast – By Technology

10.3.1 Hormonal Contraceptives

10.3.2 Barrier Contraceptives

10.4. Market Analysis, Insights and Forecast – By Distribution Channel

10.4.1 Hospital Pharmacy

10.4.2 Retail Pharmacy

10.4.3 Clinics

10.4.4 Online Channel

10.4.5 Public Channel & NGOs

10.4.6 Others

10.5. Market Analysis, Insights and Forecast – By Countries/Sub regions

10.5.1 South Africa

10.5.2 GCC

10.5.3 Rest of Middle East & Africa

11.Competitive Analysis

11.1. Key Industry Developments

11.2. Global Market Share Analysis (2017)

11.3. Competition Dashboard

11.4. Comparative Analysis – Major Players

11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))

11.5.1 Bayer AG

11.5.2 Pfizer Inc.

11.5.3 Janssen Global Services, LLC

11.5.4 Teva Pharmaceutical Industries Ltd.

11.5.5 Merck & Co., Inc.

11.5.6 Mylan N.V.

11.5.7 Allergan

11.5.8 ReckittBenckiser Group plc

11.5.9 Veru Inc.

11.5.10 Church & Dwight Co., Inc.

11.5.11 Medisafe Distribution Inc.

11.5.12 Other Prominent Players

12.Strategic Recommendation